Transurethral ventral buccal mucosa graft inlay for treatment of distal urethral strictures: international multi-institutional experience

dc.contributor.authorDaneshvar, Michael
dc.contributor.authorSimhan, Jay
dc.contributor.authorBlakely, Stephen
dc.contributor.authorAngulo Cuesta, Javier
dc.contributor.authorLucas, Jacob
dc.contributor.authorHunter, Craig
dc.contributor.authorChee, Justin
dc.contributor.authorLópez Alvarado, Damián
dc.contributor.authorRamírez Pérez, Erick Alejandro
dc.contributor.authorMadala, Alosh
dc.contributor.authorEt al.
dc.date.accessioned2022-03-09T17:19:17Z
dc.date.available2022-03-09T17:19:17Z
dc.date.issued2020
dc.description.abstractPurpose: To critically evaluate a multi-institutional patient cohort undergoing single-stage distal urethral repair using a novel transurethral buccal mucosa graft inlay urethroplasty technique (TBMGI). Methods: A retrospective multi-institutional review of consecutive patients with fossa navicularis (FN) strictures treated with a single-stage TBMGI technique at 12 institutions from March 2014-March 2018 was performed. Patient demographics, stricture characteristics, clinical and patient-reported outcomes were analyzed. The primary outcomes were stricture recurrence and complications. Secondary outcomes were change in maximum urinary flow rate (Qmax), PVR, and changes in IPSS, SHIM and global response assessment (GRA) questionnaire responses. Descriptive statistical analysis was used for evaluation of outcomes. Results: Sixty-eight men met inclusion criteria. Median age and stricture length were 60 years (IQR 48-69) and 2 cm (IQR 2-3), respectively. Most common stricture etiology was lichen sclerosus (34%). Median operative time and EBL were 72 min (IQR 50-120) and 20 mL (IQR 10-43), respectively. Fifty-seven men completed ≥ 12-month follow-up. At a median follow-up of 17 months (IQR 13-22), 54 patients (95%) remained stricture-free. Median Qmax improved from 5 to 18 mL/s (p < 0.0001), PVR 76-21 mL (p < 0.0001), and IPSS 15-5 (p < 0.0001); IPSS-QOL score: 5-1 (p < 0.0001). SHIM score did not significantly change following repair (median 22-21 p = 0.85). On GRA assessment, a majority of men reported "marked" (64%) or "moderate" (28%) overall improvement. No patient developed fistula, glanular dehiscence, graft necrosis or chordee. Conclusions: This novel minimally invasive transurethral urethroplasty technique is feasible and has demonstrated generalizable outcomes in a multi-institutional cohort with varying etiologies.spa
dc.description.filiationUEMspa
dc.description.impact4.226 JCR (2020) Q1, 21/89 Urology & Nephrologyspa
dc.description.impact1.552 SJR (2020) Q1, 8/107 Urologyspa
dc.description.impactNo data IDR 2020spa
dc.description.sponsorshipSin financiaciónspa
dc.identifier.citationDaneshvar, M., Simhan, J., Blakely, S., Angulo, J., Lucas, J., Hunter, C., Chee, J., López Alvarado, D., Ramírez Pérez, E., Madala, A., Benito, J., Martins, F., Felício, J., Rusilko, P., Flynn, B., & Nikolavsky, D. (2020). Transurethral ventral buccal mucosa graft inlay for treatment of distal urethral strictures: International multi-institutional experience. World Journal of Urology, 38(10), 2601-2607. https://doi.org/10.1007/s00345-019-03061-6spa
dc.identifier.doi10.1007/s00345-019-03061-6
dc.identifier.issn0724-4983
dc.identifier.issn1433-8726
dc.identifier.urihttp://hdl.handle.net/11268/10905
dc.language.isoengspa
dc.peerreviewedSispa
dc.rights.accessRightsrestricted accessspa
dc.subject.otherUretraspa
dc.subject.otherMucosa bucalspa
dc.subject.otherConstricción patológicaspa
dc.subject.unescoCirugíaspa
dc.titleTransurethral ventral buccal mucosa graft inlay for treatment of distal urethral strictures: international multi-institutional experiencespa
dc.typejournal articlespa
dspace.entity.typePublication
relation.isAuthorOfPublicationeaadbb3a-67c4-43f5-b477-5fb2318b809a
relation.isAuthorOfPublication.latestForDiscoveryeaadbb3a-67c4-43f5-b477-5fb2318b809a

Files